Observational Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7387-7401
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7387
Table 3 Subgroup analysis of overall survival, progression-free survival and 5-year survival
SubgroupsOS (mo)
PFS (mo)
5-yr survival (%)
Median/n, range/%
Median/n, range/%
TreatmentF-IGRT (n = 27)21.0, 0-8712.0, 0-7447.2
S-IGRT (n = 4)17.0, 3-4918.0, 2-320.0
IntentCurative (n = 23)22.0, 0-8714.0, 0-7451.5
Palliative (n = 8)8.0, 0-794, 0-1330.0
LocationOesophageal (n = 22)18, 0-8713, 0-7442.8
SCC (n = 16)20, 1-8714, 1-7462.0
AC (n = 6)10, 0-547, 0-190.0
Gastric (n=9)25, 0-7913, 0-5355.6